Rheumatoid Arthritis—A Molecular Understanding
- 18 June 2002
- journal article
- review article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 136 (12) , 908-922
- https://doi.org/10.7326/0003-4819-136-12-200206180-00012
Abstract
The application of molecular immunology techniques in the study of rheumatoid arthritis has resulted in an explosion of knowledge on the risk factors for the disease, predictors of disease severity, the molecular mechanisms of inflammatory responses, and mechanisms of tissue destruction. We know, for example, that inheriting certain genes in the major histocompatibility complex partly dictates susceptibility and severity of rheumatoid arthritis. These genes and others in the major histocompatibility complex are critical for the occurrence of immune responses both constructive (prevention of infection, surveillance for malignant cells) and destructive (development of autoimmune diseases). We also now understand mechanisms of cell communication, regulation of immune responses, how the cells that mediate immune responses and tissue injury accumulate in tissues, and how the injury occurs. The knowledge itself is satisfying, but more important, based on this knowledge, effective and reasonably safe treatments that address basic mechanisms of the disease process have been developed and are now widely used. In fact, the newer treatments represent the "tip of the iceberg," and as our basic knowledge increases, so too will the armamentarium with which we can fight rheumatoid arthritis and other similar autoimmune diseases.Keywords
This publication has 82 references indexed in Scilit:
- Adenoviral mediated delivery of FAS ligand to arthritic joints causes extensive apoptosis in the synovial liningThe Journal of Gene Medicine, 2000
- Predominance of mononuclear cells expressing the chemokine receptor CCR5 in synovial effusions of patients with different forms of arthritisArthritis & Rheumatism, 1999
- Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonistArthritis & Rheumatism, 1998
- Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1Arthritis & Rheumatism, 1994
- Transforming Growth Factor β1 Regulates Tissue Inhibitor of Metalloproteinases—1 Expression in Differentiated Human Articular ChondrocytesArthritis & Rheumatism, 1994
- Effects of administration of an anti‐cd5 plus immunoconjugate in rheumatoid arthritis. results of two phase ii studiesArthritis & Rheumatism, 1993
- The intrinsic migratory capacity of memory T cells contributes to their accumulation in rheumatoid synoviumArthritis & Rheumatism, 1992
- Rheumatoid synovium is enriched in CD45RBdim mature memory T cells that are potent helpers for B cell differentiationArthritis & Rheumatism, 1992
- Selection of T cell receptor Vβ elements by HLA‐DR determinants predisposing to Rheumatoid ArthritisArthritis & Rheumatism, 1992
- Diversity of rheumatoid synovial tissue T cells by T cell receptor analysis. Oligoclonal expansion in interleukin‐2–responsive cellsArthritis & Rheumatism, 1991